Funding Opportunity RFA-CA-21-037 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) as a part of its Beau Biden Cancer Moonshot Initiative invites submission of applications requesting support for projects that will accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP) as Recommendation I: Generation of Human Tumor Atlases. The overarching goal of this FOA is to accelerate research efforts conducted and led by the Human Tumor Atlas Network (HTAN, humantumoratlas.org) via the implementation of three-dimensional (3D) imaging technologies that will allow for a comprehensive view of the dynamic multidimensional ecosystems that define tumors in humans. Each project will lead to the multiplexed 3D characterization of at least one cancer transition investigated by the HTAN (pre-malignant to malignant, primary to metastatic, therapy responsive to resistant). The data and analytical tools generated through this FOA will be made available for use by the research and clinical communities through the activities of the HTAN Data Coordinating Center.

Notice NOT-AA-21-027 from the NIH Guide for Grants and Contracts

Notice NOT-AA-21-026 from the NIH Guide for Grants and Contracts

Notice NOT-AA-21-025 from the NIH Guide for Grants and Contracts

Notice NOT-TR-21-025 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-054 from the NIH Guide for Grants and Contracts

Notice NOT-HG-21-027 from the NIH Guide for Grants and Contracts

Notice NOT-RM-21-026 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HD-22-014 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement is to support a coordinating center for the NICHD Population Dynamics Centers Research Infrastructure Programs.

Notice NOT-RM-21-024 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-OD-21-009 from the NIH Guide for Grants and Contracts. High rates and disparities of COVID-19 infection and mortality continue among underserved and vulnerable populations across the United States. The overarching goal of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative is to understand and ameliorate factors that have placed a disproportionate burden of the pandemic on underserved and/or vulnerable populations, specifically by implementing programs that expand the scope and reach of COVID-19 testing interventions to reduce these disparities. To address barriers to testing and vaccination, social, ethical, and behavioral research is urgently needed to inform related efforts. The purpose of this Phase II RADx-UP Funding Opportunity Announcement (FOA) is to expand research to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing interventions among underserved and vulnerable populations. Proposed studies for Phase II are encouraged to move beyond descriptive health disparities research to focus on developing interventions and other actionable solutions in collaboration with community partners and stakeholders. The funding for this initiative is provided from the. American Rescue Plan Act of 2021.

Notice NOT-OD-21-101 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-103 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-OD-21-008 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) uses an emergency U01 mechanism to support Phase II of the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADx-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

£45,000 to £50,000: Wellcome Sanger Institute:  The Opportunity:  Do you want to play a key part in advancing the world’s leading cancer genomics resource? COSMIC, the Catalogue of Somatic Mutat... Hinxton, Cambridgeshire

Notice NOT-CA-21-042 from the NIH Guide for Grants and Contracts

Pension, bonus, healthcare: Paramount Recruitment: Head of Computational Biology Core Unit - South Germany! I am currently recruiting for an exciting role with a top 10 pharmaceutical company based Baden-Württemberg, Germany

Competitive Salary: EMBL: About this position We are seeking to recruit an energetic Project Leader to help develop and manage the Ensembl Plants resource (and related resou Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position EMBL-EBI is looking for four experienced PA/Section administrators. The successful candidate will act as a PA to the Section He Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position The Goldman Group at EMBL-EBI researches novel genome and protein data analysis methods. Our contributions in the past include Hinxton, Cambridgeshire, England